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1079-88 Revascularization Alone for Functional Mitral 
Regurgitation: A Propensity Case-Match Analysis of the 
Off Pump Coronary Artery Bypass Approach
Paul C. Saunders, Eugene A. Grossi, Charles F. Schwartz, Robert M. Applebaum, Greg 
H. Ribakove, Alfred T. Culliford, Aubrey C. Galloway, Stephen B. Colvin, New York 
University Medical Center, New York, NY
Objective: Patients with mild or moderate functional mitral regurgitation (MR) are at
increased risk for poor outcomes after coronary revascularization. When these patients
receive coronary revascularization alone, it is unclear if an off-pump approach (OPCAB)
affects outcomes.
Methods: 1078 patients with functional mitral regurgitation underwent CABG alone
between 1996 and 2002; 222 performed off-pump and 856 using cardiopulmonary
bypass (CPB-CABG). Using intraoperative transesophageal echocardiography (TEE),
MR was classified as mild (n=848), moderate (n=223), and severe (n=7). Propensity
analysis was used to construct matched cohorts of patients with mild and moderate MR
undergoing OPCAB(n=127) and CPB-CABG(n=127). Matching variables included age,
sex, degree of MR, ejection fraction, number of grafts performed, urgency of operation,
previous cardiac surgery, and co-morbidities such as renal disease, diabetes, atheroma-
tous aortic disease, peripheral vascular disease, COPD, history of stroke and previous
MI.
Results: Hospital mortality (6.3% vs. 5.5%, p=0.79) and mid-term(3yr.) survival (90.0%
vs. 94.9%, p=0.33) were similar between the CPB-CABG and OPCAB groups, respec-
tively. By multivariable analysis, factors associated with increased hospital mortality were
renal disease (Odds Ratio(OR)=8.4, p=0.001), reoperation (OR=5.6, p=0.08), and worse
degree of MR (OR=5.2, p=0.01). Mid-term survival was adversely affected by renal dis-
ease (OR=4.0, p=0.008), worse degree of MR (OR=2.5, p=0.07, and history of stroke or
cerebrovascular disease (OR=2.6, p=0.07).
Conclusions: Worsening insufficiency was associated with poorer outcomes in patients
with functional MR undergoing coronary revascularization alone, suggesting that they
might benefit from mitral valve intervention. Choice of technique (OPCAB vs. CPB-
CABG) was not a significant factor in hospital or mid-term mortality.
1079-101 Therapeutic Strategies and Outcomes in Patients With 
Previous Coronary Artery Bypass Graft Following a 
New Acute Coronary Syndrome: Insights From the 
GRACE Experience
Viviana Brito, Ricardo Perez de la Hoz, Edgado Sampó, Ernesto Duronto, Omar H. 
Dabbous, Neelam Gowda, Enrique P. Gurfinkel, The GRACE Investigators, Hospital San 
Martin, Buenos Aires, Argentina, ICYCC Fundación Favaloro, Buenos Aires, Argentina
Background Prior antecedents of coronary artery bypass graft (CABG) surgery are a
clinical feature of risk in patients with an acute coronary event.
Aim To compare outcomes in acute coronary syndrome (ACS) patients with a history of
CABG who were treated conservatively or invasively.
Methods and Results From a total of 30,588 patients included in this prospective analy-
sis of GRACE patients, 3794 had a history of CABG. In-hospital and 6-month follow-up
data were available from 3006 and 1638 patients, respectively. During the first 48 h, 405
patients underwent invasive treatment and 2601 conservative treatment. Antiplatelets,
antithrombins and glycoprotein (GP) IIb/IIIa inhibitors were more frequently used in the
invasive than the conservative group (aspirin 95 vs 89%; thienopyridine 88 vs 23%,
LMWH 36 vs 46%, GPIIb/IIIa 70 vs 9%; all P<0.001). Multivariate analysis was per-
formed to adjust for differences in baseline characteristics and potential confounders.
Major bleeding and stroke were more frequent in the invasive group. No difference in car-
diovascular death was observed between groups at 6-month follow-up. Using the
GRACE risk model, an initial conservative approach in patients with prior CAGB was not
related to a higher risk of in-hospital death/major bleeding.
Conclusion In spite of the imbalance in characteristics, we found no clear beneficial
trend in favor of an invasive approach and an increase in the risk of major bleeding or
stroke with this approach.
1079-102 Correlation Between Norepinephrine and Epinephrine 
Myocardial Spillover and Tumor Necrosis Factor-Alpha 
in Conventional Versus Off-Pump Coronary Artery 
Bypass Surgery
Francesco Donatelli, Michele Triggiani, Giovanni Marchetto, Andrea Moneta, Marco 
Pocar, Davide Passolunghi, Gianni Bolla, Alessio Assaghi, Barbara Sala, Orietta Borghi, 
Pino Fundarò, Pier Luigi Meroni, Luisa Gregorini, University of Milano, Milano, Italy
Background: Complete revascularization obtained by coronary artery bypass surgery
does not prevent long term left ventricular remodeling and heart failure development.
Periprocedural events linked to different surgical techniques, such as cardiopulmonary
bypass with cardioplegic arrest (CABG) versus off-pump procedures may trigger an irre-
versible microvascular dysfunction or myocytes necrosis and apoptosis.
Methods: To test this hypothesis we measured norepinephrine and epinephrine coronary
sinus and aortic spillover before and after surgery, simultaneously with Tumor Necrosis
Factor-alpha (TNF-alpha) measurements in 30 patients randomized to CABG (n=15), or
off-pump (n=15) coronary surgery. Plasma catecholamines were assessed by high per-
formance liquid chromatography and TNF-alpha by ELISA.
Results: Norepinephrine and epinephrine spillover was similar in the two groups before
surgery, being 1.38±0.62 and 1.08±0.45, respectively. After surgery norepinephrine spill-
over was 1.43±0.56, 0.72±0.49 in CABG and off-pump, respectively (P<0.05 CABG ver-
sus off-pump, means ±SD ). Epinephrine spillover was 1.27±0.16 and 0.65±0.15
respectively (P<0.05, CABG versus off-pump). TNF-alpha significantly increased only in
CABG patients being 22.17±6.79 and 35.4±5.98, pg/mL, before and after surgery
(P<0.05), respectively. After surgery norepinephrine spillover correlated with TNF-alpha
levels (P=0.01, R=0.553).
Conclusions: Patients undergoing off-pump interventions showed significantly lower cate-
cholamines spillover as compared to CABG, suggesting that the off-pump technique may
result less invasive, not only for a lower local and whole body inflammatory response but
also for a lower sympathetic drive. For the first time in humans we have detected an
increase in epinephrine-spillover after cardiac surgery. Further studies are necessary to
evaluate if the short-term advantages observed after off-pump coronary surgery translate
into a long-term attenuation of left ventricular remodeling and in the prevention of heart
failure progression.
ORAL CONTRIBUTIONS
815FO 
Featured Oral Session...Unstable 
Ischemic Syndromes: Intermediate- and 
Long-Term Outcomes
Monday, March 08, 2004, 2:00 p.m.-3:30 p.m.
Morial Convention Center, Hall A
2:15 p.m.
815-2 Long-Term Outcome of Patients With Cardiogenic 
Shock Complicating Acute Myocardial Infarction
David R. Holmes, Jr., David Hasdai, Jennifer White, Peter B. Berger, Mayo Clinic, 
Rochester, MN
INTRODUCTION: Although the early outcome of cardiogenic shock (CS) complicating
acute myocardial infarction (MI) has been well documented, the longer term outcome is
less well understood.
METHODS: The GUSTO I study enrolled patients with AMI from 1989 to 1993 and
included 1891 United States patients with CS. Vital status 9 years after study entry is
available in 1797 of whom 859 (47%) survived the first 30 days. These 859 patients form
the basis of this report.
RESULTS: Nine years after study entry, 53% of patients remained alive. Table 1 com-
pares the baseline characteristics of 30-day survivors who did and did not survive 9
years.
/
Using Cox regression methods for multivariable analysis, the following factors were sig-
nificantly associated with long-term mortality, age > 55, prior MI, diabetes, current
smoker, index revascularization all p <.001.
CONCLUSIONS: Although early mortality from cardiogenic shock remains high, those
Table 1: Crude odds ratios using the GRACE risk model (in-hospital events and 
6-month follow-up)
Variables (invasive treatment) Odds ratio 95% CI P value
Crude
Major bleeding 1.689 1.009–2.829 0.046
In-hospital death 1.036 0.614–1.748 0.895
Ischemic event 0.993 0.787–1.253 0.951
Six-month follow-up 0.865 0.646–1.159 0.332
Adjusted
Ischemic symptoms 1.026 0.801–1.312 0.841
In-hospital death 1.166 0.609–2.231 0.643
Combined endpoints 1.057 0.835–1.339 0.644
Major bleeding 1.499 0.828–2.714 0.181
Six-month follow-up 1.002 0.732–1.371 0.992
N Alive
457
Dead
402
P
Male 66.5% 65.7% .793
Age (yrs) 60.6 +/- 10.56 66.5 +/- 11.02 <.001
Diabetes 9.9% 20.6% <.001
Prior MI 10.8% 26.8% <.001
Anterior MI 37.7% 50.3% <.001
Inferior MI 60.1% 47.8% <.001
Revasc within 30 days
PTCA
CABG
PTCA or CABG
42.7%
21.9%
58.3%
28.9%
21.1%
46.3%
<.001
.763
<.001
